Jane Street
CERE

Jane Street’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History

Jane Street’s Portfolio CERE Stock Details CERE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-358,500
Closed -$14.7M – 10711
2024
Q2 		$14.7M Sell
358,500
-18,300
-5% -$762K ﹤0.01% 1607
2024
Q1 		$15.9M Buy
376,800
+56,700
+18% +$2.38M ﹤0.01% 1376
2023
Q4 		$13.6M Buy
320,100
+237,600
+288% +$6.83M ﹤0.01% 1633
2023
Q3 		$1.8M Buy
82,500
+6,200
+8% +$155K ﹤0.01% 4232
2023
Q2 		$2.43M Sell
76,300
-84,300
-52% -$2.59M ﹤0.01% 3870
2023
Q1 		$3.92M Buy
160,600
+83,300
+108% +$2.44M ﹤0.01% 2781
2022
Q4 		$2.44M Sell
77,300
-54,600
-41% -$1.54M ﹤0.01% 3547
2022
Q3 		$3.73M Buy
131,900
+123,100
+1,399% +$3.67M ﹤0.01% 3094
2022
Q2 		$233K Sell
8,800
-11,900
-57% -$338K ﹤0.01% 7984
2022
Q1 		$725K Sell
20,700
-31,700
-60% -$926K ﹤0.01% 6783
2021
Q4 		$1.7M Sell
52,400
-27,000
-34% -$953K ﹤0.01% 4810
2021
Q3 		$2.34M Buy
+79,400
New +$2.23M ﹤0.01% 4158

Other funds holding CERE

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

Jane Street's CERE Position: Q3 2024 in Review

Jane Street sold out of Cerevel Therapeutics Holdings, Inc. Common Stock (CERE) in Q3 2024, closing a stake of 269,948 shares — an estimated $11M sold.

Jane Street first reported a position in CERE in Q2 2021 and held it in 10 quarters. The position peaked at $11M in Q2 2024. 2 funds tracked by Wall St. Rank hold CERE as of Q3 2024.

  • Jane Street reported no remaining Cerevel Therapeutics Holdings, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • Jane Street sold 269,948 Cerevel Therapeutics Holdings, Inc. Common Stock shares in Q3 2024, an estimated $11M.
  • Jane Street first reported a position in Cerevel Therapeutics Holdings, Inc. Common Stock in Q2 2021 and held it in 10 quarters.
  • Jane Street's Cerevel Therapeutics Holdings, Inc. Common Stock position peaked at $11M in Q2 2024.
  • 2 funds tracked by Wall St. Rank held Cerevel Therapeutics Holdings, Inc. Common Stock as of Q3 2024.

Based on Jane Street's 13F filing for Q3 2024, filed 15 Nov 2024.